Authors: Ryuji Asano,Amon Nagami,Yuki Fukumoto,Kaori Miura,Futoshi Yazama,Hideyuki Ito,Isao Sakata,Akihiro Tai
Journal: Bioorganic and Medicinal Chemistry Letters
https://doi.org/10.1016/j.bmcl.2014.01.054
Abstract: New boron-containing chlorin derivatives 9 and 13 as agents for both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT) of cancer were synthesized from photoprotoporphyrin IX dimethyl ester (2) and l-4-boronophenylalanine-related compounds. The in vivo biodistribution and clearance of 9 and 13 were investigated in tumor-bearing mice. The time to maximum accumulation of compound 13 in tumor tissue was one-fourth of that of compound 9, and compound 13 showed rapid clearance from normal tissues within 24 h after injection. The in vivo therapeutic efficacy of PDT using 13 was evaluated by measuring tumor growth rates in tumor-bearing mice with 660 nm light-emitting diode irradiation at 3 h after injection of 13. Tumor growth was significantly inhibited by PDT using 13. These results suggested that 13 might be a good candidate for both PDT and BNCT of cancer. {textcopyright} 2014 Elsevier Ltd. All rights reserved.
Categories
Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer
Bioorganic and Medicinal Chemistry Letters, 2014